Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection

British Journal of Dermatology

Volumn 149, Issue 2, 2003, Pages 390-394

  Willems, M ^a   Munte, K ^a   Vrolijk, J M ^a   Den Hollander, J C ^a   Bohm M ^b   Kemmeren, M H ^a   De Man, R A ^a   Brouwer, J T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Chronic hepatitis C; Combination therapy; Hyperpigmentation; Interferon alpha; Skin

Indexed keywords

ALPHA INTERFERON; ALPHA INTERMEDIN; MELANIN; RIBAVIRIN; TYROSINE;

ADULT; ANAMNESIS; ARTICLE; CAMEROON; CASE REPORT; CLINICAL EXAMINATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER BIOPSY; MALE; NETHERLANDS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY;

ANTIVIRAL AGENTS; DRUG ERUPTIONS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON ALFA-2B; MALE; MIDDLE AGED; TONGUE DISEASES;

EID: 0041411170     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05422.x     Document Type: Article

References (15)

1. Braunwald E, Fauci AS, Isselbacher KJ et al. Harrison's Online (http://www.harrisonsonline.com). Cited 2001, New York: McGraw-Hill Co.
2. Nordlund JJ. Postinflammatory hyperpigmentation. Dermatol Clin 1988; 6: 185-92.
3. Chen YT, Stockert E, Jungbluth A et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996; 93: 5915-19.
4. Schiller M, Raghunath M, Kubitscheck U et al. Human dermal fibroblasts express prohormone convertases 1 and 2 and produce proopiomelanocortin-derived peptides. J Invest Dermatol 2001; 117: 227-35.
5. Doutre MS. Hepatitis C virus-related skin diseases. Arch Dermatol 1999; 135: 1401-3.
6. Sookoian S, Neglia V, Castano G et al. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1.
7. Hearing VJ. The melanosome: the perfect model for cellular responses to the environment. Pigment Cell Res 2000; 13 (Suppl. 8): 23-34.
8. Abdel-Malek Z, Scott MC, Suzuki I et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 2000; 13 (Suppl. 8): 156-62.
9. Schwahn DJ, Xu W, Herrin AB et al. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation. Pigment Cell Res 2001; 14: 32-9.
10. Kameyama K, Montague PM, Hearing VJ. Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons. J Cell Physiol 1988; 137: 35-44.
11. Kameyama K, Tanaka S, Ishida Y, Hearing VJ. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest 1989; 83: 213-21.
12. Mooy WJ, Krausz T. Biopsy Pathology of Melanocytic Disorders. 1st edn. London: Chapman & Hall, 1992: 2.
13. Catania A, Airaghi L, Garofolo L et al. The neuropeptide alpha-MSH in HIV infection and other disorders in humans. Ann NY Acad Sci 1998; 840: 848-56.
14. Ghanem G, Verstegen J, De Rijcke S et al. Studies on factors influencing human plasma alpha-MSH. Anticancer Res 1989; 9: 1691-6.
15. Holzmann H, Altmeyer P, Stohr L, Chilf GN. Modification of alpha-MSH by UVA irradiation of the skin [German]. Hautarzt 1983; 34: 294-7.